Article
Muscle transcriptome profiling reveals novel molecular pathways and biomarkers in laminin-α2 deficient patients.
Acta neuropathologica communications - 3 Feb 2026
Pini Veronica, Catapano Francesco, Bonaccorso Rosa, Weisburd Ben, Previtali Stefano C, Muntoni Francesco
Abstract excerpt
Merosin-deficient congenital muscular dystrophy (LAMA2-RD) is a neuromuscular disorder caused by mutations in the LAMA2 gene, coding for the α2 subunit of laminin-211 (merosin). LAMA2 mutations leading to complete laminin-211 absence result in a severe clinical phenotype with profound muscle weakness and respiratory insufficiency, whereas mutations allowing the production of a partially functional protein are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
